Cabaletta Bio Inc (CABA)

Jan 31, 2026

History Review: Is Cabaletta Bio Inc stock a smart retirement pickJuly 2025 Patterns & High Conviction Investment Ideas - baoquankhu1.vn

Jan 31, 2026

Jan 30, 2026

What Makes Cabaletta Bio, Inc. (CABA) a Strong Momentum Stock: Buy Now? - Yahoo Finance

Jan 30, 2026

Jan 28, 2026

Cabaletta Bio, Inc. (NASDAQ:CABA) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat

Jan 28, 2026

Jan 27, 2026

Guggenheim reiterates Buy rating on Cabaletta Bio stock, citing commercial plan - Investing.com Nigeria

Jan 27, 2026

Jan 27, 2026

Cabaletta Bio: Do You Buy With The Insiders? (NASDAQ:CABA) - Seeking Alpha

Jan 27, 2026

Jan 27, 2026

Is Cabaletta Bio (CABA) Outperforming Other Medical Stocks This Year? - Yahoo Finance

Jan 27, 2026

Jan 27, 2026

Largest borrow rate increases among liquid names - TipRanks

Jan 27, 2026

Jan 26, 2026

Assessing Cabaletta Bio (CABA) Valuation After Insider Buying And FDA Clearance For Automated CAR T Manufacturing - Yahoo Finance

Jan 26, 2026

Jan 25, 2026

Stock Analysis: Does Cabaletta Bio Inc have pricing powerWeekly Trend Recap & Daily Growth Stock Investment Tips - baoquankhu1.vn

Jan 25, 2026

Jan 25, 2026

Strategic Partnerships Propel Cabaletta Bio Forward - StocksToTrade

Jan 25, 2026

Jan 25, 2026

Cabaletta Bio Unveils Strategic Plans Amid Price Target Revision - timothysykes.com

Jan 25, 2026

Jan 24, 2026

Cabaletta Bio Aims High with Strategic Initiatives for 2026​ - StocksToTrade

Jan 24, 2026

Jan 24, 2026

Steven Nichtberger Bought 3.3% More Shares In Cabaletta Bio - Sahm

Jan 24, 2026

Jan 23, 2026

Returns Recap: Is Cabaletta Bio Inc stock trending bullishGap Down & Community Verified Trade Signals - baoquankhu1.vn

Jan 23, 2026

Jan 23, 2026

Cabaletta Bio Unveils Strategic Plans Amid Financial Forecast Changes - StocksToTrade

Jan 23, 2026

Jan 23, 2026

Cabaletta Bio Stock (CABA) Opinions on Insider Buying and Clinical Updates - Quiver Quantitative

Jan 23, 2026

Jan 23, 2026

Cabaletta targets 2027 FDA filing as autoimmune CAR-T push accelerates - MSN

Jan 23, 2026

Jan 23, 2026

Cabaletta Bio Advances Rese-cel Toward Pivotal Milestones, Expands Autoimmune Cell Therapy Pipeline - RTTNews

Jan 23, 2026

Jan 23, 2026

Why Cabaletta Bio (CABA) Is Up 41.3% After FDA Clears Automated CAR T Manufacturing Platforms - Yahoo Finance

Jan 23, 2026

Jan 23, 2026

Cabaletta Bio to Present Pioneering Clinical Data on Rese-cel at Major Scientific Conferences - MSN

Jan 23, 2026

Jan 22, 2026

Cabaletta Bio Sees Unusually Large Options Volume (NASDAQ:CABA) - MarketBeat

Jan 22, 2026

Jan 22, 2026

Cabaletta Bio (CABA) Shares Surge 11% After Insider Buying - GuruFocus

Jan 22, 2026

Jan 22, 2026

Cabaletta Bio stock jumps 11% premarket after insider buying cluster hits the tape - TechStock²

Jan 22, 2026

Jan 22, 2026

Cabaletta Bio, Inc. (NASDAQ:CABA) institutional owners may be pleased with recent gains after 9.7% loss over the past year - simplywall.st

Jan 22, 2026

Jan 22, 2026

Simon Mark, Cabaletta bio director, buys $25,261 in shares By Investing.com - Investing.com UK

Jan 22, 2026

Jan 22, 2026

Cabaletta Bio (CABA) CEO Nichtberger buys $100,777 in shares By Investing.com - Investing.com UK

Jan 22, 2026

Jan 21, 2026

Biotech Stocks Surge After Hours: IO Biotech Jumps 19%, Cue Biopharma And Cabaletta Bio Follow - Nasdaq

Jan 21, 2026

Jan 21, 2026

Cabaletta Bio Insiders Go on a Buying Spree, Signaling Strong Confidence From the Top - TipRanks

Jan 21, 2026

Jan 21, 2026

Insider Buying: Michael Gerard Acquires Shares of Cabaletta Bio Inc (CABA) - GuruFocus

Jan 21, 2026

Jan 21, 2026

Insider Buying: Steve Gavel Acquires Shares of Cabaletta Bio Inc (CABA) - GuruFocus

Jan 21, 2026

Jan 21, 2026

Steven Nichtberger Acquires 45,000 Shares of Cabaletta Bio (NASDAQ:CABA) Stock - MarketBeat

Jan 21, 2026

Jan 21, 2026

Cabaletta Bio (NASDAQ:CABA) Director Mark Simon Acquires 11,061 Shares - MarketBeat

Jan 21, 2026

Jan 21, 2026

Cabaletta Bio (NASDAQ:CABA) Insider Gwendolyn Binder Buys 11,312 Shares - MarketBeat

Jan 21, 2026

Jan 21, 2026

Insider Buying: Cabaletta Bio (NASDAQ:CABA) Insider Acquires 8,800 Shares of Stock - MarketBeat

Jan 21, 2026

Jan 21, 2026

Michael Gerard Purchases 6,600 Shares of Cabaletta Bio (NASDAQ:CABA) Stock - MarketBeat

Jan 21, 2026

Jan 21, 2026

Cabaletta Bio (NASDAQ:CABA) Director Shawn Tomasello Acquires 22,725 Shares - MarketBeat

Jan 21, 2026

Jan 21, 2026

Cabaletta Bio (NASDAQ:CABA) Insider Acquires 22,170 Shares - MarketBeat

Jan 21, 2026

Jan 21, 2026

Gerard, Cabaletta bio general counsel, buys $14.9k in CABA By Investing.com - Investing.com Australia

Jan 21, 2026

Jan 21, 2026

Cabaletta Bio (CABA) CEO Nichtberger buys $100,777 in shares - Investing.com

Jan 21, 2026

Jan 21, 2026

Simon Mark, Cabaletta bio director, buys $25,261 in shares - Investing.com

Jan 21, 2026

Jan 20, 2026

Cabaletta Targets 2027 FDA Filing as Autoimmune CAR-T Push Accelerates - mychesco.com

Jan 20, 2026

Jan 19, 2026

JPM26: Beam, Cabaletta, More Zero In on Regulatory Alignment After Tumultuous Year - BioSpace

Jan 19, 2026

Jan 16, 2026

Guidance Update: Is Cabaletta Bio Incs ROIC above industry averageJuly 2025 Trade Ideas & Stepwise Trade Execution Plans - baoquankhu1.vn

Jan 16, 2026

Jan 16, 2026

Portfolio Recap: Can Cabaletta Bio Inc disrupt its industryOil Prices & Daily Stock Trend Watchlist - baoquankhu1.vn

Jan 16, 2026

Jan 16, 2026

Is Cabaletta Bio Incs ROIC above industry averageMarket Growth Summary & Low Drawdown Momentum Ideas - baoquankhu1.vn

Jan 16, 2026

Jan 16, 2026

Cabaletta Bio stock rating reiterated by Cantor Fitzgerald on IND clearance By Investing.com - Investing.com South Africa

Jan 16, 2026

Jan 16, 2026

Cabaletta Bio stock rating reiterated by Cantor Fitzgerald on IND clearance - Investing.com South Africa

Jan 16, 2026

Jan 12, 2026

CABA Initiates Key Trials and Advances Manufacturing for Rese-Ce - GuruFocus

Jan 12, 2026